thalidomide has been researched along with trimethoprim, sulfamethoxazole drug combination in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fenollar, F; Lagier, JC; Lepidi, H; Liozon, E; Raoult, D | 1 |
| Almeida, DF; Cavalcante, RS; Dos Santos, AR; Finato, AC; Mendes, RP; Nascimento, DC; Paniago, AMM; Soares, CT; Venturini, J | 1 |
2 other study(ies) available for thalidomide and trimethoprim, sulfamethoxazole drug combination
| Article | Year |
|---|---|
Successful treatment of immune reconstitution inflammatory syndrome in Whipple's disease using thalidomide.
Topics: Humans; Immune Reconstitution Inflammatory Syndrome; Immunosuppressive Agents; Male; Middle Aged; Thalidomide; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination; Whipple Disease | 2010 |
Evaluation of antifibrotic and antifungal combined therapies in experimental pulmonary paracoccidioidomycosis.
Topics: Animals; Antifungal Agents; Azithromycin; Cytokines; Disease Models, Animal; Drug Therapy, Combination; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Itraconazole; Male; Mice; Mice, Inbred BALB C; Paracoccidioides; Paracoccidioidomycosis; Pentoxifylline; Pulmonary Fibrosis; Random Allocation; Thalidomide; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 2020 |